Opill

The FDA has approved O-Pill, a non-prescription daily oral contraceptive, making it the first of its kind in the US. Dr. Patrizia from the FDA stated that this approval offers a new option for millions of people. Daily oral contraception, when used correctly, is safe and more effective in preventing unintended pregnancies compared to other non-prescription methods. This is important because nearly half of the 6.1 million pregnancies in the US each year are unintended, leading to negative outcomes. The O-Pill will likely be available for purchase in stores and online in early 2024. Hello and welcome to medtalksdaily, now on today's episode, oral contraceptive pills. Recently FDA approves O-Pill as first non-prescription daily oral contraceptive pills. In a groundbreaking move, the US FDA has granted approval to O-Pill, known as Nogestril, tablet for non-prescription use as a daily oral contraceptive. This marks the first time that a non-prescription oral contraceptive has been approved for use in the US without a prescription. Dr. Patrizia, the director of the FDA's Center for Drug Evaluation and Research, expressed today's approval marks the first time of a non-prescription daily oral contraceptive will be an available option for millions of people in the United States. Daily oral contraception when used as directed is considered safe and expected to be more effective in preventing unintended pregnancies compared to currently available non-prescription oral contraceptive methods. In the United States, almost half of the 6.1 million pregnancies each year are unintended and such pregnancies have been linked to negative maternal and perinatal outcomes. The availability of non-prescription O-Pill may help reduce the number of unintended pregnancies and their associated negative impacts. The pill's manufacturer, Paris-based HRA Pharma, said the contraceptive would most likely be available at stores and online retailers nationwide in early 2024.